324 results on '"Gulley, Margaret"'
Search Results
2. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
3. Low Epstein–Barr Virus Prevalence in Cardia Gastric Cancer Among a High-Incidence Chinese Population
4. Purity Independent Subtyping of Tumors (PurIST) Pancreatic Cancer Classifier: Analytic Validation of a 16-RNA Expression Signature Distinguishing Basal and Classical Subtypes
5. Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements
6. Variation in risk and outcomes of Epstein–Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies : an exploratory study
7. Current and Emerging Molecular Tests for Human Papillomavirus–Related Neoplasia in the Genomic Era
8. Karyotypic abnormalities associated with Epstein–Barr virus status in classical Hodgkin lymphoma
9. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology
10. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns
11. Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia
12. Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America
13. Molecular Oncology Testing in Resource-Limited Settings
14. Calibration of cell-free DNA measurements by next-generation sequencing.
15. Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas
16. Phase I Clinical Trial of Valacyclovir and Standard of Care Cyclophosphamide in Children With Endemic Burkitt Lymphoma in Malawi
17. Integrated genomic characterization of oesophageal carcinoma
18. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
19. Quality Assurance of RNA Expression Profiling in Clinical Laboratories
20. Genetic Tests To Evaluate Prognosis and Predict Therapeutic Response in Acute Myeloid Leukemia
21. Comprehensive genomic characterization of head and neck squamous cell carcinomas
22. CpG Methylation Analysis—Current Status of Clinical Assays and Potential Applications in Molecular Diagnostics: A Report of the Association for Molecular Pathology
23. High levels of Epstein–Barr virus DNA in latently infected gastric adenocarcinoma
24. Epstein-Barr Virus Infection Is Common in Inflamed Gastrointestinal Mucosa
25. Laboratory Assays for Epstein-Barr Virus-Related Disease
26. Comprehensive molecular characterization of gastric adenocarcinoma
27. Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma
28. Epstein-Barr Virus Latent Membrane Protein 1 is not Associated with Vessel Density nor with Hypoxia Inducible Factor 1 Alpha Expression in Nasopharyngeal Carcinoma Tissue
29. Case–case comparison of smoking and alcohol risk associations with Epstein–Barr virus-positive gastric cancer
30. Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis
31. Use of Spiked Normalizers to More Precisely Quantify Tumor Markers and Viral Genomes by Massive Parallel Sequencing of Plasma DNA
32. Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting
33. Standard Mutation Nomenclature in Molecular Diagnostics: Practical and Educational Challenges
34. Clonal evolution of lymphoblastoid cell lines
35. Epstein-Barr Viral Load Measurement as a Marker of EBV-related Disease
36. Diagnosis of Human Congenital Cytomegalovirus Infection by Amplification of Viral DNA from Dried Blood Spots on Perinatal Cards
37. Detection of Common Disease-Causing Mutations in Mitochondrial DNA (Mitochondrial Encephalomyopathy, Lactic Acidosis with Stroke-Like Episodes MTTL1 3243 A>G and Myoclonic Epilepsy Associated with Ragged-Red Fibers MTTK 8344A>G) by Real-Time Polymerase Chain Reaction
38. Validation of Roche LightCycler Epstein-Barr Virus Quantification Reagents in a Clinical Laboratory Setting
39. The usefulness of cytogenetic analysis in fine needle aspirates for the histologic subtyping of sarcomas
40. Viral response to chemotherapy in Burkitt lymphoma
41. Post-transplantation Lymphoproliferative Disease: Epstein-Barr Virus DNA Levels, HLA-A3, and Survival
42. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma
43. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations
44. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
45. No evidence of Epstein–Barr virus association with Merkel cell carcinoma
46. False-Negative Factor V Leiden Genetic Testing in a Patient With Recurrent Deep Venous Thrombosis
47. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
48. Epstein-Barr Virus As a Marker of Survival After Hodgkin’s Lymphoma: A Population-Based Study
49. Epstein-Barr Viral Load as a Marker of Lymphoma in AIDS Patients
50. Epstein-Barr Virus Quantitation by Real-Time PCR Targeting Multiple Gene Segments: A Novel Approach to Screen for the Virus in Paraffin-Embedded Tissue and Plasma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.